Moderna on April 28 said it has asked the U.S. Food and Drug Administration (FDA) to grant emergency use authorization (EUA) to the company for its COVID-19 vaccine for children as young as 6 months. The EUA submission is for two 25-microgram doses of the shot, mRNA-1273, in children 6 months old to 5 years old….
WHO Backs Pfizer’s Oral COVID-19 Therapy for High-Risk Patients
The World Health Organization (WHO) on April 21 endorsed the use of Pfizer Inc.’s oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by the U.N. agency showed the therapy dramatically cut the risk of hospitalization. Of existing COVID-19 treatments, Pfizer’s Paxlovid is by far the most potent, the WHO said….
3 in 4 US Children Have Had COVID-19: CDC Estimate
Three of four children in America have had COVID-19, along with over six in 10 young adults, according to new estimates. Research from the Centers for Disease Control and Prevention (CDC) found that only a quarter of children 17 and younger have no signs of having had COVID-19. The research, which analyzed blood samples submitted for…
Vitamin D Supplementation Is Effective in Preventing COVID-19, Study Suggests
April 26, 2022
admin
BrightCCP VirusCovid NewsCOVID-19healthHealth NewsNews & DiscoveriesnutritionprophylaxisPUBLIC HEALTH INFORMATIONsupplementsVitamin D
0 Comment
Vitamin D supplementation can help prevent COVID-19 without serious adverse events, regardless of the individual’s vitamin D status, a study suggests. The peer-reviewed study, published in the Archives of Medical Research, enrolled 321 frontline health care workers from four hospitals in Mexico City, who all tested negative for COVID-19 at the start of the study. “The results of…
Severe Infections 5 Times More Likely Among Sinovac Than Pfizer COVID-19 Vaccine Recipients: Study
April 24, 2022
admin
Asia & PacificBrightCCP VirusChinaCovid NewsCOVID-19healthHealth NewsINSIDE CHINAPfizerSingaporeSinovacVaccineVaccines & SafetyWorld
0 Comment
The China-made Sinovac-CoronaVac vaccine is the least effective in preventing infection or severe symptoms among COVID-19 patients compared to the Sinopharm, Moderna, and Pfizer-BioNTech/Comirnaty vaccines, according to a recently published study from Singapore. “We observed a lower relative effectiveness of two inactivated whole virus vaccines (Sinovac-CoronaVac and Sinopharm) against COVID-19 infection compared with two mRNA…
Some Vaccine Injured Getting Better While Others See Little Improvement
Some people who experienced adverse reactions to the COVID-19 vaccines are recovering from their injuries after spending months working to find treatments, though others have seen little improvement. Dr. Danice Hertz, who was diagnosed with an adverse reaction to Pfizer’s COVID-19 vaccine, has had ups and downs since getting the jab in December 2020. During one…
CDC Assessing Whether a Mask Mandate Is Still Needed After Ruling
The U.S. Centers for Disease Control and Prevention (CDC) is trying to determine whether a mask mandate on airplanes and other modes of other transportation is still needed after a federal judge ruled the mandate violated federal law, the agency told The Epoch Times. “CDC continues to recommend that people wear masks in all indoor…
CDC Study: Remote Learning Hurt Children’s Mental Health
When schools pivoted to remote learning amid the COVID-19 pandemic, the first casualty was children’s mental health. A new study by the Centers for Disease Control and Prevention (CDC) analyzed teenagers’ mental health from January 2021 to June 2021. Compared with 2019, the study found that the proportion of mental health-related emergency department visits in…
BA.2 Omicron Subvariant Now Causes Nearly 90 Percent of US COVID-19 Cases: CDC
The BA.2 Omicron subvariant of the CCP virus is being pegged as responsible for causing the vast majority of COVID-19 cases in the United States, according to new data from the Centers for Disease Control and Prevention (CDC). The data, for the week ending April 9 and released by the federal health agency on April 12, indicates…
Two COVID-19 Treatments Show Promise in Trials
April 12, 2022
admin
BrightCCP VirusCovid NewsCOVID-19healthHealth NewsNews & DiscoveriespandemicPUBLIC HEALTH INFORMATION
0 Comment
Two COVID-19 treatments that have not yet been authorized for administration were successful in clinical trials, the companies behind the drugs announced on April 11. A pill developed to attack cancer was successful in curbing deaths among COVID-19 patients in hospitals deemed high risk for Acute Respiratory Distress Syndrome, according to U.S.-based Veru Inc., the maker…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`